StageZero Life Sciences Ltd T.SZLS

After an emotional day

[Nolo]

Nothing has changed for me. I'm sure we all got cold sweat when we saw the numbers but not all of us reacted to them the same way obviously. Some positive points from this day:

1-The sp took a hit but not as much as I thought it would have in the circumstances. There was a bit of a panic selling at the last moment of the day but if not for that, we were closing at .125, which is not so bad. Might still be some difficult days ahead but it won't matter in the long run.

2-75% of that huge number in bracket is due to the warrant repricing. The situation is not pretty, far from it, but I'm sure that number scared many people today and some shady individuals that we all know too well jumped on this occasion to further their agenda. Even when the SH site was down, they used other forums to do it: https://ceo.ca/gen  If we had any doubts about their intentions, I'm sure they are all gone now.

3-The test volume IS increasing, hence that sentence in the NR: ''Test volume at approximately 1600 tests showed an increase over Q4 and is showing growth in Q2 as the new programs are launched.' So, we already have an insight into Q2 right there.'' We have to remember that Telehealth was launched on April 1st. The results announced today are those for the first three months of operation, not including April. 

4-Focus on Aristotle: This might intimidate short-term investors because Aristotle is not ready yet but GEN intend to work on this test and probably use it to spearhead their marketing plans.

5-International market: ''The Company is in discussion with an international distributor for the marketing of the Company's tests in Europe and other territories. Initial focus will be on ColonSentry^®.'' That could help us a lot. We will get known in Europe with ColonSentry and I'm sure the other tests will be introduced there shortly after. 

So, all in all, it's not that bad. Call me a dreamer but I'm keeping my shares.